Suppr超能文献

设计、开发和应用会话代理于成人脑相关神经状况康复治疗中的研究进展:综述

Design, development, and use of conversational agents in rehabilitation for adults with brain-related neurological conditions: a scoping review.

机构信息

College of Nursing and Health Sciences, Flinders University, Adelaide, SA, Australia.

Caring Futures Institute, College of Nursing and Health Sciences, Flinders University, Adelaide, SA, Australia.

出版信息

JBI Evid Synth. 2023 Feb 1;21(2):326-372. doi: 10.11124/JBIES-22-00025.

Abstract

OBJECTIVE

The objective of this review was to identify how conversational agents are designed and used in rehabilitation for adults with brain-related neurological conditions.

INTRODUCTION

Adults with brain-related neurological conditions experience varied cognitive and functional challenges that can persist long term. However, rehabilitation services are time- and resource-limited, and novel rehabilitation approaches are warranted. Conversational agents provide a human-computer interface with which the user can converse. A conversational agent can be designed to meet specific user needs, such as rehabilitation and support.

INCLUSION CRITERIA

Studies focused on the design and use of conversational agents for rehabilitation for people aged 18 years or older with brain-related neurological conditions were considered for inclusion. Eligible publication types included peer-reviewed publications (quantitative, qualitative, and/or mixed methods study designs; research protocols; peer-reviewed expert opinion papers; clinical studies, including pilot trials; systematic or scoping reviews), full conference papers, and master's or PhD theses. Eligible types of research included prototype development, feasibility testing, and clinical trials.

METHODS

Online databases, including MEDLINE, Scopus, ProQuest (all databases), Web of Science, and gray literature sources were searched with no date limit. Only English publications were considered due to a lack of resourcing available for translations. Title and abstract screening and full-text review were conducted by two independent reviewers. Data extraction was shared by three independent reviewers. The data extraction instrument was iteratively refined to meet the requirements of all included papers, and covered details for technological aspects and the clinical context. Results are presented narratively and in tabular format, with emphasis on participants, concept and context, and data extraction instrument components.

RESULTS

Eleven papers were included in the review, which represented seven distinct conversational agent prototypes. Methodologies included technology description (n = 9) and initial user testing (n = 6). The intended clinical cohorts for the reported conversational agents were people with dementia (n = 5), Parkinson disease (n = 2), stroke (n = 1), traumatic brain injury (n = 1), mixed dementia and mild cognitive impairment (n = 1), and mixed dementia and Parkinson disease (n = 1). Two studies included participants who were healthy or otherwise from the general community. The design of the conversational agents considered technology aspects and clinical purposes. Two conversational agent prototypes incorporated a speaking humanoid avatar as reported in five of the papers. Topics of conversation focused on subjects enjoyable to the user (life history, hobbies, where they lived). The clinical purposes reported in the 11 papers were to increase the amount of conversation the user has each day (n = 4), reminiscence (n = 2), and one study each for anxiety management and education, Parkinson disease education, to obtain and analyze a recording of the user's voice, to monitor well-being, and to build rapport before providing daily task prompts. One study reported clinician oversight of the conversational agent use. The studies had low sample sizes (range: 1-33). No studies undertook effectiveness testing. Outcome measures focused on usability, language detection and production, and technological performance. No health-related outcomes were measured. No adverse events were reported, and only two studies reported safety considerations.

CONCLUSIONS

Current literature reporting the design and use of conversational agents for rehabilitation for adults with brain-related neurological conditions is heterogeneous and represents early stages of conversational agent development and testing. We recommend, as per our customized data extraction instrument, that studies of conversational agents for this population clearly define technical aspects, methodology for developing the conversation content, recruitment methods, safety issues, and requirements for clinician oversight.

摘要

目的

本综述旨在确定对话代理在针对大脑相关神经状况的成人康复中的设计和使用方式。

介绍

大脑相关神经状况的成年人会经历各种认知和功能挑战,这些挑战可能会持续很长时间。然而,康复服务受到时间和资源的限制,因此需要新的康复方法。对话代理提供了一种人机交互界面,用户可以通过该界面进行对话。对话代理可以根据特定用户的需求进行设计,例如康复和支持。

纳入标准

研究对象为年龄在 18 岁或以上的大脑相关神经状况患者,关注的是对话代理的设计和康复应用。纳入的研究类型包括同行评议的出版物(定量、定性和/或混合方法研究设计;研究方案;同行评议的专家意见论文;临床研究,包括试点试验;系统或范围综述)、完整的会议论文以及硕士或博士论文。研究类型包括原型开发、可行性测试和临床试验。

方法

在线数据库(包括 MEDLINE、Scopus、ProQuest[所有数据库]、Web of Science 和灰色文献来源)进行无时间限制的搜索。由于缺乏翻译资源,仅考虑英文出版物。由两名独立评审员进行标题和摘要筛选以及全文审查。三名独立评审员共同进行数据提取。数据提取工具经过迭代完善,以满足所有纳入文献的要求,并涵盖技术方面和临床背景的详细信息。结果以叙述性和表格形式呈现,重点介绍参与者、概念和背景以及数据提取工具组件。

结果

综述纳入了 11 篇论文,代表了 7 种不同的对话代理原型。方法学包括技术描述(n=9)和初步用户测试(n=6)。报告的对话代理的预期临床队列为痴呆症患者(n=5)、帕金森病患者(n=2)、中风患者(n=1)、创伤性脑损伤患者(n=1)、混合性痴呆症和轻度认知障碍患者(n=1)以及混合性痴呆症和帕金森病患者(n=1)。两项研究纳入了来自一般社区的健康或其他人群的参与者。对话代理的设计考虑了技术方面和临床目的。两个对话代理原型在五篇论文中报告了采用了具有说话人形化身的代理。对话的主题集中在用户感兴趣的主题上(生活史、爱好、居住地点)。11 篇论文报告的临床目的是增加用户每天的对话量(n=4)、怀旧(n=2)、一项研究用于焦虑管理和教育、帕金森病教育、获取和分析用户的语音录音、监测幸福感以及在提供日常任务提示之前建立融洽关系。一项研究报告了临床医生对对话代理使用的监督。这些研究的样本量较小(范围:1-33)。没有研究进行有效性测试。结果衡量指标侧重于可用性、语言检测和生成以及技术性能。未测量健康相关结果。没有报告不良事件,只有两项研究报告了安全考虑因素。

结论

目前报告针对大脑相关神经状况的成年人康复中使用的对话代理的设计和使用的文献具有异质性,代表了对话代理开发和测试的早期阶段。我们建议,根据我们定制的数据提取工具,针对该人群的对话代理研究应明确规定技术方面、开发对话内容的方法、招募方法、安全问题以及临床医生监督的要求。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验